| Previous Close | 5.55 |
| Open | 5.83 |
| Bid | 5.30 x 300 |
| Ask | 5.90 x 1400 |
| Day's Range | 5.83 - 5.83 |
| 52 Week Range | 4.36 - 8.12 |
| Volume | 591 |
| Avg. Volume | 768 |
| Net Assets | 898.08k |
| NAV | 5.77 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | -29.23% |
| Beta (3y) | 0.64 |
| Expense Ratio (net) | 0.75% |
| Inception Date | 2008-06-24 |
- Zacks•3 months ago
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon
- Zacks•3 months ago
Best and Worst Zones of Q1 and Their ETFs
Most corners of ETF investing have performed exceptionally well in Q1 while a few areas are lagging.
- Investopedia•3 months ago
Best and Worst Zones of Q1 and Their ETFs
The rally in the global stock market continued with Trump-fueled optimism and expectation of faster growth. In fact, stocks scaled multiple highs on several occasions in the first quarter amid bouts of ...